About the Episode

Vaccine earnings may be transitory, but “I’m optimistic that the setup for the back half of this year will be more constructive” for the healthcare sector, said Michael Rich, CFA, Research Analyst at Eagle Asset Management. Rich joins Matt Orton, CFA, Director and Portfolio Specialist at Carillon Tower Advisers, to explain the innovations in the works that may provide investor opportunity.

About our Guest

Michael Rich, CFA, is a Research Analyst for the Eagle Asset Management equity team. Rich joined Eagle Asset Management in June 2016 after six years at Raymond James. He has significant experience researching the healthcare sector.